Pharmaceutical - Pharmaceutical, Gastro-intestinals

Filter

Popular Filters

1 to 25 of 175 results

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Tenfold growth by 2023 forecast for celiac disease drug market

Tenfold growth by 2023 forecast for celiac disease drug market

08-01-2015

The celiac disease treatment market value will expand more than tenfold from an estimated $49.6 million…

AbbVieEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Takeda gains approval for Takecab in Japan; files MS drug NDA

Takeda gains approval for Takecab in Japan; files MS drug NDA

29-12-2014

Japan’s largest drugmaker Takeda Pharmaceutical and partner Otsuka Pharmaceuticals have been granted…

Gastro-intestinalsGlatiramer AcetateJapanNeurologicalOtsuka PharmaceuticalsPharmaceuticalRegulationTakecabTakeda PharmaceuticalTeva Pharmaceuticals Industriesvonoprazan

Insulin therapeutics specialist Nutrinia completes $12 million financing round

Insulin therapeutics specialist Nutrinia completes $12 million financing round

18-12-2014

Nutrinia, a developer of oral insulin therapies to treat rare gastrointestinal disorders in babies, has…

Business FinanceEndocrine systemGastro-intestinalsNutriniaPharmaceutical

Janssen returns rights of IBD drug GLPG1205 to Galapagos

Janssen returns rights of IBD drug GLPG1205 to Galapagos

17-12-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has returned the rights to…

GalapagosGastro-intestinalsJanssenJanssen PharmaceuticaLicensingPharmaceutical

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

12-12-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalPricingRegulationRemicadeSimponi InjectionUK

Takeda partners with Monash University on gastrointestinal research

Takeda partners with Monash University on gastrointestinal research

10-12-2014

Japan’s largest drugmaker Takeda has entered into a research partnership with the Monash Institute…

AustraliaGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticals

AstraZeneca’s Moventig gains EU approval for OIC

09-12-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaEuropeGastro-intestinalsMoventigNektar TherapeuticsPharmaceuticalRegulation

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

District Court sets accelerated date to resolve Takeda suit against FDA over Colcrys

District Court sets accelerated date to resolve Takeda suit against FDA over Colcrys

10-11-2014

The US District Court for the District of Columbia, presiding in a law suit between Japanese drugmaker…

ColcrysGastro-intestinalsHikmaLegalPharmaceuticalTakeda PharmaceuticalUSAWest-Ward

FDA responds to Public Citizen antacid petition from 2011

FDA responds to Public Citizen antacid petition from 2011

05-11-2014

The US Food and Drug Administration has responded to a 2011 petition from consumer rights advocacy group…

Gastro-intestinalsNexiumPharmaceuticalPrevacidPrilosecRegulationUSA

Added benefit of Takeda’s Entyvio is not proven, says IQWiG

Added benefit of Takeda’s Entyvio is not proven, says IQWiG

04-11-2014

In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products,…

EntyvioGastro-intestinalsGermanyPharmaceuticalPricingRegulationTakeda Pharmaceutical

New drugs could drive celiac disease market to over $550 million by 2023, says analyst

New drugs could drive celiac disease market to over $550 million by 2023, says analyst

31-10-2014

The launches of Alba/Teva Pharmaceutical Industries’ larazotide acetate and Alvine/AbbVie’s latiglutenase…

AbbVieAlba TherapeuticAlvine PharmaceuticalsEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Receptos rockets on positive mid-stage results for UC drug candidate

29-10-2014

US discovery and development company Receptos saw its shares rocket 47% to a new high, after it announced…

Gastro-intestinalsNeurologicalPharmaceuticalReceptosResearchRPC1063

Eisai and Arena announce top line results of lorcaserin HCl with phentermine HCl

Eisai and Arena announce top line results of lorcaserin HCl with phentermine HCl

29-10-2014

Japanese drug major Eisai and Arena Pharmaceuticals have announced top-line results of a pilot study…

Arena PharmaceuticalsEisaiGastro-intestinalsJapanlorcaserinPharmaceuticalPhentermine HydrochlorideResearch

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Gastroenterologists underestimate Crohn’s disease and UC in patients

Gastroenterologists underestimate Crohn’s disease and UC in patients

27-10-2014

Most physicians underestimate the severity of moderate or severe inflammatory bowel disease, specifically…

AbbVieGastro-intestinalsPharmaceuticalResearchUSA

Takeda gains exclusive rights to Amitiza beyond US and Canada

Takeda gains exclusive rights to Amitiza beyond US and Canada

23-10-2014

US biopharma company Sucampo Pharmaceuticals saw its shares rise 5.6% to $8.46 in morning trading, after…

AmitizaGastro-intestinalsGlobalLicensingPharmaceuticalSucampoTakeda Pharmaceutical

Ferring Pharma’s Cortiment gains EU approval

Ferring Pharma’s Cortiment gains EU approval

23-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says its Cortiment (budesonide) treatment…

CortimentCosmo PharmaceuticalsEuropeFerring PharmaceuticalsGastro-intestinalsPentasaPharmaceuticalRegulation

Actavis signs option to acquire relamorelin developer

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisDiabetesGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

03-10-2014

Gastrointestinal specialist Salix Pharmaceuticals is reportedly seeking a deal with Ireland-headquartered…

ActavisCosmo PharmaceuticalsGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalSalixUSA

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

02-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical today announced new data from a Phase III study of…

EntyvioGastro-intestinalsJapanPharmaceuticalResearchTakeda Pharma

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

01-10-2014

Gastrointestinal specialist Salix Pharmaceuticals and Progenix Pharmaceuticals have had their Relistor…

Gastro-intestinalsPharmaceuticalProgenics PharmaceuticalsRegulationRelistorSalix PharmaceuticalsUSA

1 to 25 of 175 results

Back to top